文献速递放射性药物与辐射防护骨显像与常规 SPECT核素与放射性配体治疗

生物剂量学在因放射学、影像学或核医学操作而受低剂量辐射患者中的临床应用

Clinical Applications of Biological Dosimetry in Patients Exposed to Low Dose Radiation Due to Radiological, Imaging or Nuclear Medicine Procedures.
PubMed 文献 · Semin Nucl Med · 2021-12-06

本综述汇总了生物剂量学方法在因X线诊断、CT、介入放射学、低剂量放疗及核医学(内部给予131I等放射性药物)等医学照射而受低剂量辐射患者中的应用数据,涵盖生物剂量学基本方面及其在低剂量范围的局限性、体内辐射生物标志物诱导的主要模式,并分析了造影剂效应、儿童患者辐射响应、磁共振成像影响、辐射防护剂评价、患者异常内在放射敏感性检测及医学辐射事故受照者剂量估算等特定问题。综述还提出了基于γ-H2AX焦点、双着丝粒和易位分析联合应用的多参数生物剂量学平台作为内照射和/或低剂量外照射高级生物剂量学的潜在方法,并指出需进一步研究以通过严格的生物剂量学方法学阐明患者医学辐射安全问题。

要点

  • 细胞遗传学检测可个体化定量患者辐射效应并评估各类医学照射模式的遗传毒性。
  • 综述涵盖X线诊断、CT、介入放射学、低剂量放疗及核医学内照射的生物标志物诱导模式。
  • 提出γ-H2AX焦点、双着丝粒和易位分析联合的多参数平台用于内照射和/或低剂量外照射。

核心结论

  • 生物剂量学方法可用于个体化定量患者医学低剂量照射的辐射效应并估算辐射相关癌症风险预后所需剂量。
  • 综述指出需进一步研究以通过严格的生物剂量学方法学阐明患者医学辐射安全问题。

研究设计与样本

  • 综述汇总了生物剂量学方法在因各种医学照射而受低剂量辐射患者中应用的数据。
  • 涵盖X线诊断、计算机断层扫描、介入放射学、低剂量放疗及核医学(内部给予131I和其他放射性药物)等临床照射场景。

主要发现

  • 细胞遗传学检测在评估各种医学照射模式遗传毒性和为辐射相关癌症风险预后提供有意义剂量估算方面具有高能力。
  • 综述分析了造影剂效应、儿童患者辐射响应、磁共振成像影响、辐射防护剂评价、患者异常内在放射敏感性检测及医学辐射事故受照者剂量估算等特定问题。
  • 未来改进方向包括细胞遗传学分析自动化、分子生物剂量学指标引入和多参数生物剂量学平台开发。

局限性

  • 综述指出生物剂量学在低辐射剂量范围存在局限性。
  • 综述指出需进一步研究以通过严格的生物剂量学方法学阐明患者医学辐射安全问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiation dosimetric biomarkers have found applications beyond radiation protection area and now are actively introduced into clinical practice. Cytogenetic assays appeared to be a valuable tool for individualized quantifying radiation effects in patients, with high capability for assessing genotoxicity of various medical exposure modalities and providing meaningful radiation dose estimates for prognoses of radiation-related cancer risk. This review summarized current data on the use of biological dosimetry methods in patients undergoing various medical irradiations to low doses. The highlighted topics include basic aspects of biological dosimetry and its limitations in the range of low radiation doses, and main patterns of in vivo induction of radiation biomarkers in clinical exposure scenarios, occurring in X-ray diagnostics, computed tomography, interventional radiology, low dose radiotherapy, and nuclear medicine (internally administered 131I and other radiopharmaceuticals). Additionally, several specific issues, examined by biodosimetry techniques, are analysed, such as contrast media effect, radiation response in pediatric patients, impact of magnetic resonance imaging, evaluation of radioprotectors, detection of patients' abnormal intrinsic radiosensitivity and dose estimation in persons involved in medical radiation incidents. A prognosis of possible directions for further improvements in this area includes the automation of cytogenetic analysis, introduction of molecular biodosimeters and development of multiparametric biodosimetry platforms. A potential approach to the advanced biodosimetry of internal exposure and/or low dose external irradiation is suggested; this can be a multiparametric platform based on the combination of the γ-H2AX foci, dicentric, and translocation assays, each applied in the optimum postexposure time range, with the amalgamation of the dose estimates. The study revealed the necessity of further research, which might clarify medical radiation safety concerns for patients via using stringent biodosimetry methodology.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Vinnikov V, Belyakov O. Clinical Applications of Biological Dosimetry in Patients Exposed to Low Dose Radiation Due to Radiological, Imaging or Nuclear Medicine Procedures. Semin Nucl Med. 2021. PMID: 34879905. doi:10.1053/j.semnuclmed.2021.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。